MILLENNIUM PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 25066
 
  
 
C07D HETEROCYCLIC COMPOUNDS 15745
 
  
 
C07K PEPTIDES 12735
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9972
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 5746
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5768
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 51155
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 3337
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2921
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2475

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0066,068 ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPYApr 21, 15Mar 08, 18[A61K, G01N, C07K]
2018/0051,086 METHOD OF TREATING PRIMARY SCLEROSING CHOLANGITISMar 04, 16Feb 22, 18[A61K, C07K]
2017/0360,926 PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODYDec 23, 15Dec 21, 17[A61K, G01N, C07K]
2017/0326,119 NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITORDec 20, 16Nov 16, 17[A61K, C07D]
2017/0327,584 Vedolizumab for the Treatment of Fistulizing Crohn's DiseaseNov 25, 15Nov 16, 17[A61K, G01N, C07K]
2017/0281,551 SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTIONApr 25, 17Oct 05, 17[A61J, A61K]
2017/0173,033 PHARMACEUTICAL FORMULATIONS OF A PAN-RAF KINASE INHIBITOR, PROCESSES FOR THEIR PREPARATION, AND METHODS OF USEMar 26, 15Jun 22, 17[A61K]
2017/0158,686 Compounds Useful as Raf Kinase InhibitorsDec 15, 16Jun 08, 17[A61K, C07F, C07D]
2017/0136,024 INHIBITORS OF E1 ACTIVATING ENZYMESJul 20, 16May 18, 17[A61K]
2017/0105,995 BIOMARKERS OF RESPONSE TO NAE INHIBITORSJun 03, 16Apr 20, 17[A61K, C12Q, G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920048 Substituted pyrimidines for inhibiting Raf kinase activityDec 15, 16Mar 20, 18[A61K, C07F, C07D]
9920373 Biomarkers of response to proteasome inhibitorsNov 09, 12Mar 20, 18[A61K, C12Q, G01N, G06F]
9873693 Methods of treatment using pyridinonyl PDK1 inhibitorsJul 10, 14Jan 23, 18[A61K, C07D]
9862745 Synthesis of boronic ester and acid compoundsJan 08, 16Jan 09, 18[C07F, C07K]
9850214 Inhibitors of NEDD8-activating enzymeJul 08, 14Dec 26, 17[A61K, C07D]
9827246 Biomarkers of response to NAE inhibitorsOct 26, 12Nov 28, 17[A61K, C12Q, G01N, G06F]
9828590 Molecules of the card-related protein family and uses thereofJun 17, 15Nov 28, 17[A61K, C12Q, C12N, G01N, C07K]
9802938 Sulfamoylating reagentsNov 25, 14Oct 31, 17[C07D, C07C]
9802960 Heteroaryls and uses thereofJan 13, 15Oct 31, 17[A61K, C07D]
9796725 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzymeApr 17, 17Oct 24, 17[C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0107,579 E1 ENZYME MUTANTS AND USES THEREOFAbandonedJun 01, 16Apr 20, 17[A61K, C12Q, G01N]
2017/0073,367 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINESAbandonedDec 23, 14Mar 16, 17[C07H, C07D]
2016/0287,601 ENHANCED TREATMENT REGIMENS USING PI3K INHIBITORSAbandonedOct 02, 14Oct 06, 16[A61K]
2016/0271,249 COMBINATION OF AURORA KINASE INHIBITORS AND ANTI-CD20 ANTIBODIESAbandonedFeb 25, 16Sep 22, 16[A61K, C07K]
2016/0250,238 Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus NephritisAbandonedOct 02, 14Sep 01, 16[A61K]
2016/0123,960 METHOD FOR PREPARING THREE-DIMENSIONAL, ORGANOTYPIC CELL CULTURES AND USES THEREOFAbandonedJun 10, 14May 05, 16[G01N]
2016/0039,789 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOFAbandonedMay 28, 14Feb 11, 16[C07D]
2016/0031,913 BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOFAbandonedOct 12, 15Feb 04, 16[C07F]
2016/0008,382 METHODS OF TREATMENT OF CANCERAbandonedJan 23, 13Jan 14, 16[A61K, G01N]
2015/0361,105 PROTEASOME INHIBITORSAbandonedAug 24, 15Dec 17, 15[A61K, C07F]
2015/0184,246 BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORSAbandonedNov 09, 12Jul 02, 15[A61K, C12Q, G06F]
2015/0175,542 THIOLACTAMS AND USES THEREOFAbandonedOct 29, 14Jun 25, 15[C07D]
2015/0175,614 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOFAbandonedDec 18, 14Jun 25, 15[C07D]
2015/0133,439 QUINAZOLINE DERIVATIVES AS KINASE INHIBITORSAbandonedJul 09, 14May 14, 15[C07D]
2015/0119,410 BIOMARKERS OF RESPONSE TO NAE INHIBITORSAbandonedOct 26, 12Apr 30, 15[A61K, C12Q, G01N, G06F]
2015/0112,071 PREPARATION OF AMINOTETRALIN COMPOUNDSAbandonedMay 29, 14Apr 23, 15[C07D]
2015/0072,942 BORONIC ESTER AND ACID COMPOUNDS, SYNTHESIS AND USESAbandonedApr 08, 14Mar 12, 15[C07K]
2015/0038,706 SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDSAbandonedMar 06, 14Feb 05, 15[C07F, C07K]
2015/0030,601 E1 ENZYME MUTANTS AND USES THEREOFAbandonedOct 05, 12Jan 29, 15[C12Q, C12N, G01N, C07K]
2014/0371,207 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOFAbandonedDec 13, 13Dec 18, 14[C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.